Back
Day Range
$36.22
$90.00
52-Week Range
$10.24
$90.00
Volume
10
50D / 200D Avg
$10.24
/
$10.30
Prev Close
$10.24
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -13.1 | 0.3 |
| P/B | 5.2 | 2.9 |
| ROE % | -34.9 | 3.7 |
| Net Margin % | -12.0 | 3.8 |
| Rev Growth 5Y % | -10.2 | 10.0 |
| D/E | 0.9 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$0.44
$0.42 – $0.48
|
1.9 B | 1 |
| FY2029 |
-$0.05
-$0.06 – -$0.05
|
1.7 B | 1 |
| FY2028 |
-$0.28
-$0.31 – -$0.27
|
1.5 B | 1 |
Key Takeaways
Revenue declined -10.15% annually over 5 years
Negative free cash flow of -55.21M
PEG of 0.05 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 20.77%
Capital efficient — spends only 2.54% of revenue on capex
Growth
Revenue Growth (5Y)
-10.15%
Revenue (1Y)10.62%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-34.90%
ROIC-11.15%
Net Margin-11.95%
Op. Margin-8.62%
Safety
Debt / Equity
0.92
Current Ratio1.83
Interest Coverage0.00
Valuation
P/E Ratio
-13.09
P/B Ratio5.18
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 10.62% | Revenue Growth (3Y) | 7.73% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -10.15% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.13B | Net Income (TTM) | -134.46M |
| ROE | -34.90% | ROA | -17.28% |
| Gross Margin | 0.00% | Operating Margin | -8.62% |
| Net Margin | -11.95% | Free Cash Flow (TTM) | -55.21M |
| ROIC | -11.15% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.92 | Current Ratio | 1.83 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -13.09 | P/B Ratio | 5.18 |
| P/S Ratio | 1.56 | PEG Ratio | 0.05 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.76B | Enterprise Value | 1.98B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.13B | 1.02B | 969.46M | 930.97M | 1.73B |
| Net Income | -134.46M | -97.25M | 82.28M | -171.12M | -225.74M |
| EPS (Diluted) | -2.60 | -8.25 | -10.07 | -15.88 | -23.40 |
| Gross Profit | 0.0 | 216.54M | 203.35M | 160.15M | 260.05M |
| Operating Income | -96.95M | -104.22M | 89.70M | 40.49M | 106.81M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 778.13M | 866.42M | 1.10B | 1.27B | 1.28B |
| Total Liabilities | 438.02M | 435.89M | 748.67M | 784.29M | 746.74M |
| Shareholders' Equity | 340.11M | 430.53M | 350.78M | 484.92M | 531.74M |
| Total Debt | 312.21M | 330.82M | 528.64M | 525.15M | 526.43M |
| Cash & Equivalents | 95.37M | 54.03M | 126.04M | 277.74M | 300.61M |
| Current Assets | 213.57M | 293.67M | 395.88M | 537.14M | 539.27M |
| Current Liabilities | 116.48M | 180.32M | 241.35M | 212.54M | 156.66M |